Background: Epidermolysis Bullosa is associated with poor dermal-epidermal cohesion, leading to the formation of blisters, erosions and scars on the skin and mucous membranes in response to minimal mechanical trauma. It is clinically and genetically heterogeneous, comprising phenotypes with different levels of severity. A definitive cure does not appear to be forthcoming, with symptomatic treatment being the most commonly used approach. However, various studies and clinical trials have been carried out with the aim of testing different theories and finding an effective method for improving the quality of life of people with this condition and mitigating its negative effects. Objectives: The aim of this study is to gather complete and up-to-date information on the main therapeutic strategies used and/or under development for Epidermolysis Bullosa. Material and Methods: A literature review was carried out, searching the Pubmed, Google Scholar and Scielo databases for the keywords "epidermolysis bullosa", "treatment" and "pharmacotherapy", selecting articles using the inclusion and exclusion criteria. Results: Based on the articles included in this review, it was possible to understand the different existing strategies for the treatment of Epidermolysis Bullosa. It was found that there are various types of therapies under development, although the results obtained are promising. Conclusion: As this is a very heterogeneous pathology, it is difficult to find a therapy that is effective and does not cause serious adverse effects. This is an area that should continue to be studied, with the aim of improving the quality of life of those affected.